                         SEQUENCE LISTING

<110>  CohBar Inc.
 
<120>  THERAPEUTIC PEPTIDES

<130>  32701/54014A

<150>  US 62/887,202
<151>  2019-08-15

<150>  US 62/887,278
<151>  2019-08-15

<150>  US 62/887,253
<151>  2019-08-15

<150>  US 62/887,185
<151>  2019-08-15

<150>  US 62/887,116
<151>  2019-08-15

<160>  29    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or an amino acid having a non-polar side chain; Xaa
       is absent if Xaa2 is absent

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<400>  1

Xaa Xaa His Gln Ser His Xaa Tyr His Ile Val Lys Pro Ser Pro 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Met Thr His Gln Ser His Ala Tyr His Ile Val Lys Pro Ser Pro 
1               5                   10                  15  


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Thr His Gln Ser His Ala Tyr His Ile Val Lys Pro Ser Pro 
1               5                   10                  


<210>  4
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-Ala

<400>  4

Thr His Gln Ser His Ala Tyr His Ile Val Lys Pro Ser Pro 
1               5                   10                  


<210>  5
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-Ala

<400>  5

His Gln Ser His Ala Tyr His Ile Val Lys Pro Ser Pro 
1               5                   10              


<210>  6
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<400>  6

Xaa Trp Phe Asp Tyr Phe Ala Met Ser Pro Ser Ala Asp Glu Gly Leu 
1               5                   10                  15      


Thr Leu Xaa Xaa 
            20  


<210>  7
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Met Trp Phe Asp Tyr Phe Cys Met Ser Pro Ser Ile Asp Glu Gly Leu 
1               5                   10                  15      


Thr Leu Leu Val 
            20  


<210>  8
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

Trp Phe Asp Tyr Phe Cys Met Ser Pro Ser Ile Asp Glu Gly Leu Thr 
1               5                   10                  15      


Leu Leu Val 
            


<210>  9
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Trp Phe Asp Tyr Phe Cys Met Ser Pro Ser Ile Asp Glu Gly Leu Thr 
1               5                   10                  15      


Leu 
    


<210>  10
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Trp Phe Asp Tyr Phe Ala Met Ser Pro Ser Ala Asp Glu Gly Leu Thr 
1               5                   10                  15      


Leu 
    


<210>  11
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is absent if Xaa14 is absent; if Xaa14 is present, then Xaa 
       is an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is absent or an amino acid having a polar side chain; Xaa is 
       absent if Xaa14 is absent

<400>  11

Xaa Val Lys Gly Asp Ser Lys Tyr Ser Glu Ala Cys Arg Xaa Xaa Xaa 
1               5                   10                  15      


<210>  12
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  12

Met Val Lys Gly Asp Ser Lys Tyr Ser Glu Ala Cys Arg Arg Val Lys 
1               5                   10                  15      


<210>  13
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

Val Lys Gly Asp Ser Lys Tyr Ser Glu Ala Cys Arg Arg Val Lys 
1               5                   10                  15  


<210>  14
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  14

Val Lys Gly Asp Ser Lys Tyr Ser Glu Ala Cys Arg Arg Val 
1               5                   10                  


<210>  15
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  15

Val Lys Gly Asp Ser Lys Tyr Ser Glu Ala Cys Arg 
1               5                   10          


<210>  16
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<400>  16

Xaa Xaa Leu Phe Phe Arg Ser Ser Lys Leu Gln Tyr Gly Arg Leu Phe 
1               5                   10                  15      


Arg Ser Xaa Xaa Xaa 
            20      


<210>  17
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  17

Met Val Leu Phe Phe Arg Ser Ser Lys Leu Gln Tyr Gly Arg Leu Phe 
1               5                   10                  15      


Arg Ser Leu Val Gly 
            20      


<210>  18
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  18

Val Leu Phe Phe Arg Ser Ser Lys Leu Gln Tyr Gly Arg Leu Phe Arg 
1               5                   10                  15      


Ser Leu Val Gly 
            20  


<210>  19
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  19

Val Leu Phe Phe Arg Ser Ser Lys Leu Gln Tyr Gly Arg Leu Phe Arg 
1               5                   10                  15      


Ser Leu Ala 
            


<210>  20
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  20

Leu Phe Phe Arg Ser Ser Lys Leu Gln Tyr Gly Arg Leu Phe Arg Ser 
1               5                   10                  15      


Ala 
    


<210>  21
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is absent or an amino acid having a non-polar side chain

<400>  21

Xaa Xaa Trp Leu Arg Leu Ser Gly Ser Lys Val Glu Trp Val Xaa Xaa 
1               5                   10                  15      


<210>  22
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  22

Met Val Trp Leu Arg Leu Ser Gly Ser Lys Val Glu Trp Val Trp Gly 
1               5                   10                  15      


<210>  23
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  23

Val Trp Leu Arg Leu Ser Gly Ser Lys Val Glu Trp Val Trp Gly 
1               5                   10                  15  


<210>  24
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-Ala

<400>  24

Val Trp Leu Arg Leu Ser Gly Ser Lys Val Glu Trp Val Trp 
1               5                   10                  


<210>  25
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Ala

<400>  25

Ala Trp Leu Arg Leu Ser Gly Ser Lys Val Glu Trp Val 
1               5                   10              


<210>  26
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  26

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala 
1               5                   10      


<210>  27
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  27

Tyr Gly Arg Lys Lys Arg Arg 
1               5           


<210>  28
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  28

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  29
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  29

Arg Arg Gln Arg Arg 
1               5   


